Cara Care is a digital therapeutics company transforming digestive healthcare through science-backed technology. Their app empowers individuals with gastrointestinal conditions like IBS, IBD, GERD, and dyspepsia to take control of their health through personalized tracking, symptom analysis, and evidence-based therapy recommendations. Clinical studies validate their impact: 70.2% of users achieve significant, clinically relevant symptom reduction.
Founded in 2016 by physicians Dr. André Sommer and Jesaja Brinkmann, Cara Care combines medical expertise with behavioral design to create a holistic, patient-centered solution. The Berlin-based company operates as a CE-certified Class 1 medical device in Europe and is available by prescription, making digital therapeutics accessible to patients through Germany's healthcare system. In December 2024, HiDoc Technologies GmbH (the company behind Cara Care) was acquired by Bayer, marking a significant milestone in their mission to eradicate the stigma around gut health and expand access to evidence-based digestive care globally.
